Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind, Factorial, Parallel-Group, Active and Placebo-Controlled, Multicenter Dose-Ranging Study to Evaluate the Efficacy, Safety and Tolerability of Six Dose Combinations of Solifenacin Succinate and Mirabegron Compared to Mirabegron and Solifenacin Succinate Monotherapies in the Treatment of Overactive Bladder.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01340027
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:09.806834+00:00
Published At
2015-07-21T00:00:00+00:00
Record Updated At
2024-10-31
Results Posted At
2015-07-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Urologic Diseases", "Urinary Bladder Diseases", "Urological Manifestations", "Signs and Symptoms", "Urinary Bladder, Overactive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-31"
protocolSection.identificationModule.nctId
"NCT01340027"
protocolSection.identificationModule.officialTitle
"A Randomized, Double-Blind, Factorial, Parallel-Group, Active and Placebo-Controlled, Multicenter Dose-Ranging Study to Evaluate the Efficacy, Safety and Tolerability of Six Dose Combinations of Solifenacin Succinate and Mirabegron Compared to Mirabegron and Solifenacin Succinate Monotherapies in the Treatment of Overactive Bladder."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-07-21"

Study condition terms

  • Urologic Diseases (protocolSection.conditionsModule.conditions)
  • Urinary Bladder Diseases (protocolSection.conditionsModule.conditions)
  • Urological Manifestations (protocolSection.conditionsModule.conditions)
  • Signs and Symptoms (protocolSection.conditionsModule.conditions)
  • Urinary Bladder, Overactive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.